Julie L. Gerberding Merck & Co., Inc. (MRK) insider trading activity

MRK Quotes by TradingView

Julie L. Gerberding is EVP, Chief Patient Officer of Merck & Co., Inc.. Currently has a direct ownership of 48,712 shares of MRK, which is worth approximately $5.71 Million. The most recent transaction as insider was on May 02, 2015, when has been sold 3,818 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.7K
0% 3M change
0% 12M change
Total Value Held $5.71 Million

Julie L. Gerberding Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2015
BUY
Exercise of conversion of derivative security
-
3,818 Added 13.09%
25,359 Common Stock
Feb 23 2015
BUY
Grant, award, or other acquisition
$159,509 $58.3 p/Share
2,736 Added 11.35%
21,374 Common Stock

Also insider at

HLVX
HilleVax, Inc. Healthcare
Director
JLG

Julie L. Gerberding

EVP, Chief Patient Officer
Kenilworth, NJ

Track Institutional and Insider Activities on MRK

Follow Merck & Co., Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRK shares.

Notify only if

Insider Trading

Get notified when an Merck & Co., Inc. insider buys or sells MRK shares.

Notify only if

News

Receive news related to Merck & Co., Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRK